Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 45 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 9896445

    Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

    Ansana BioSciences, LLC · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted
  2. US 9889081

    Aldehyde dehydrogenase inhibitors as novel depigmenting agents

    The Board of Regents of the University of Texas System · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  3. US 9890126

    Synthesis of novel inhibitors of isoprenoid biosynthesis (ISPF)

    Beryllium Discovery Corp. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  4. US 9890163

    Inhibitors of protein kinases

    Princeton Drug Discovery, Inc · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  5. US 9885042

    miR-92 inhibitors and uses thereof

    MIRAGEN THERAPEUTICS, INC. · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  6. US 9884841

    Small molecule inhibitors of Mcl-1 and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  7. US 9884807

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  8. US 9884868

    TGF-beta inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  9. US 9878993

    DNA-PK inhibitors for treatment of cancer

    Vertex Pharmaceuticals Incorporated · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted
  10. US 9878996

    2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase

    Northwestern University · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted
  11. US 9878992

    GDF-8 inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted
  12. US 9873718

    Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics

    The Regents of the University of California · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  13. US 9873696

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  14. US 9873685

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  15. US 9868736

    Deubiquitinase inhibitors and methods for use of the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted
  16. US 9862679

    Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  17. US 9855252

    Methods of treating keratin hyperproliferation disorders using mTOR inhibitors

    PALVELLA THERAPEUTICS, INC. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  18. US 9856262

    Analogues of 4H-pyrazolo[1,5-a] benzimidazole compound as PARP inhibitors

    Medshine Discovery Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  19. US 9855305

    Pharmaceutical composition containing combinations of vitamins, minerals, probiotics, and prebiotics effective in preventing adverse effects associated with the use of proton-pump inhibitors

    Compass Therapeutics LLC · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  20. US 2017369501

    KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATIONS

    4SC AG [DE] · Granted Dec 28, 2017 · Expires Dec 23, 2037

    granted
  21. US 9850207

    Substituted piperidines as soluble epdxide hydrolase inhibitors

    The Regents of the University of California · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted
  22. US 9849109

    Autotaxin inhibitors and uses thereof

    AMIRA PHARMACEUTICALS, INC. · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted
  23. US 9845332

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted
  24. US 9840460

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted